Want to join the conversation?
During 1Q16, $CLX reported lower free cash flow of $107MM or about 8% of sales compared to 1Q15. This decline was largely due to higher employee incentive compensation payments related to strong FY15 results. Looking forward, $CLX anticipates free cash flow for FY16 to be about 10% of sales.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)